Wennie Chang張力文
About Wennie Chang張力文
Wennie Chang is the Business Unit Director of Immuno-Oncology at Bristol-Myers Squibb, with over two decades of experience in the pharmaceutical and medical aesthetics industries.
Title
Wennie Chang張力文 currently holds the title of Business Unit Director, Immuno-Oncology at Bristol-Myers Squibb.
Current Roles at Bristol-Myers Squibb
Wennie Chang張力文 is actively serving as the Business Unit Director, Immuno-Oncology at Bristol-Myers Squibb. Concurrently, she also holds the position of Business Unit Director, Specialty Care in New York, New York, United States.
Current Role at Allergan
Since November 2017, Wennie Chang張力文 has been the Business Unit Head, Medical Aesthetics for Allergan, overseeing operations in Taiwan and Hong Kong.
Previous Positions
Wennie Chang張力文 boasts a rich professional history, having worked at various leading pharmaceutical companies. She served as Director, Commercialization Excellence at Bristol-Myers Squibb in Taiwan and Hong Kong from 2012 to 2014. Prior to that, she was the BU Director, Vaccines at GSK from 2010 to 2012. She also held the role of Associate BU Director, Medication Delivery at Baxter International Inc. from 2007 to 2010 and was Marketing Manager at Merck from 2001 to 2006.
Education
Wennie Chang張力文 holds a Bachelor of Science degree from Taipei Medical University and a Master of Science degree from the University of New Haven.
Industry Experience
With over two decades of experience in the pharmaceutical and medical aesthetics industries, Wennie Chang張力文 has a comprehensive background in commercialization excellence and specialty care. Her career spans significant roles in both the US and Taiwan, providing her with a broad international perspective.